Published in Br J Hosp Med on May 01, 1986
Incidence and recognition of malnutrition in hospital. BMJ (1994) 5.73
Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol (1990) 2.67
Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ (1988) 2.28
A randomised controlled trial evaluating the use of enteral nutritional supplements postoperatively in malnourished surgical patients. Gut (2000) 1.85
Hypothermia and thermoregulatory derangements induced by valproic acid. Neurology (2000) 1.64
Serum bile acids in the diagnosis of hepatobiliary disease. Gut (1977) 1.63
Mechanisms of exercise limitation in hypertrophic cardiomyopathy. J Am Coll Cardiol (1992) 1.57
Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res (1997) 1.54
Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut (1990) 1.51
Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J (1990) 1.49
A comparison between oral and nasogastric nutritional supplements in malnourished patients. Nutrition (1997) 1.48
Skin content of 7-dehydrocholesterol in patients with malabsorption. Nutrition (1997) 1.42
Spontaneous dissection of native coronary arteries. Heart (2005) 1.41
Home parenteral nutrition: the first twelve months. Scott Med J (1982) 1.40
Potential hazards of excluded bowel and use of parenteral nutrition: a case report. Nutrition (1998) 1.39
Optimal stent positioning in coronary arteries: partial balloon inflation to overcome cardiac cycle-related motion of the stent/delivery system. Catheter Cardiovasc Interv (2000) 1.39
Chlorpromazine & appetite. J Am Geriatr Soc (1991) 1.38
Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation (1992) 1.38
Gas-liquid chromatographic assay of serum bile acids. Anal Biochem (1977) 1.36
Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose. Clin Pharmacol Ther (1985) 1.20
Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects. J Clin Pharmacol (1981) 1.07
Serum bile acids in hepatobiliary disease. Gut (1978) 1.06
Fasting and postprandial serum bile acid concentrations in normal persons using an improved GLC method. Digestion (1978) 1.02
Pseudohyperkalaemia and infectious mononucleosis. Postgrad Med J (1980) 1.01
Determination of arginine and methylated arginines in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl (2000) 0.99
Determination of antimigraine compounds rizatriptan, zolmitriptan, naratriptan and sumatriptan in human serum by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom (2000) 0.98
HPLC determination of guaifenesin with selected medications on underivatized silica with an aqueous-organic mobile phase. J Pharm Biomed Anal (2000) 0.98
Idiopathic dilated cardiomyopathy. BMJ (1990) 0.97
Improved sample extraction before liquid chromatography of prednisone and prednisolone in human serum. Clin Chem (1982) 0.97
Stent longitudinal flexibility: a comparison of 13 stent designs before and after balloon expansion. Catheter Cardiovasc Interv (2000) 0.97
Serum bile acids in patients with hyperlipidaemia. J Clin Pathol (1978) 0.95
Plasma levels of clobazam after three oral dosage forms in health subjects. J Clin Pharmacol (1978) 0.95
Does hypothermia protect against the development of hepatitis in paracetamol overdose? Anaesthesia (1992) 0.94
Carbamazepine treatment of a patient with Klüver-Bucy syndrome. J Clin Psychiatry (1985) 0.93
Akathisia following traumatic brain injury: treatment with bromocriptine. J Neurol Neurosurg Psychiatry (1989) 0.93
Lysis of human macrophages by cytolytic CD4+ T cells fails to affect survival of intracellular Mycobacterium bovis-bacille Calmette-Guérin (BCG). Clin Exp Immunol (1995) 0.93
Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity? J Autoimmun (1990) 0.91
Comparison of coronal bacterial leakage between immediate versus delayed post-space preparation in root canals filled with Resilon/Epiphany. Int Endod J (2009) 0.90
The effect of dietary yeast on the activity of stable chronic Crohn's disease. Scand J Gastroenterol (1992) 0.89
A randomized study of direct coronary stent delivery compared with stenting after predilatation: the NIR future trial. On behalf of the NIR Future Trial Investigators. Catheter Cardiovasc Interv (2000) 0.89
Screening sigmoidoscopy: a randomised trial of invitation style. Health Bull (Edinb) (2000) 0.89
HPLC-photolysis-electrochemical detection in pharmaceutical analysis: application to the determination of spironolactone and hydrochlorothiazide in tablets. J Chromatogr Sci (1990) 0.88
Legionnaires' disease caused by Legionella longbeachae and Legionella pneumophila: comparison of clinical features, host-related risk factors, and outcomes. Clin Microbiol Infect (2010) 0.87
Antigenic heterogeneity of strains of Saccharomyces cerevisiae and Candida albicans recognised by serum antibodies from patients with Crohn's disease. FEMS Microbiol Immunol (1992) 0.87
Stent deformation following simulated side-branch dilatation: a comparison of five stent designs. Catheter Cardiovasc Interv (1999) 0.86
Serum bile acids in patients with viral hepatitis. Scand J Gastroenterol (1978) 0.85
Surgical specialties affect scheduling. Hospitals (1971) 0.84
Disposition of bupropion in healthy volunteers and subjects with alcoholic liver disease. J Clin Psychopharmacol (1990) 0.84
Liver metastases from an occult breast carcinoma presenting as acute fulminant hepatic failure. Br J Clin Pract (1984) 0.84
Acute diarrhoea in the elderly. Age Ageing (1980) 0.84
Plasma level studies of penbutolol after oral dose in man. J Clin Pharmacol (1977) 0.83
In vitro and in vivo bioequivalence of commercial prednisone tablets. Biopharm Drug Dispos (1985) 0.83
Chiral analysis of selected dopamine receptor antagonists in serum using capillary electrophoresis with cyclodextrin additives. J Pharm Biomed Anal (2000) 0.83
Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4 degrees C. Am J Health Syst Pharm (1996) 0.83
Lower limb cellulitis: features associated with length of hospital stay. J Infect (2006) 0.82
Fluorometric determination of chlorzoxazone in tablets and biological fluids. J Pharm Sci (1979) 0.82
Colorimetric determination of isoniazid with 9-chloroacridine. J Pharm Sci (1975) 0.82
Ethanol lock in the management of catheter occlusion. JPEN J Parenter Enteral Nutr (1987) 0.82
Paradoxical aggressive effect of propranolol in a patient with Huntington's disease. J Clin Psychiatry (1987) 0.81
Crohn's disease in the elderly. Br Med J (Clin Res Ed) (1985) 0.81
Determination of ondansetron and its hydroxy metabolites in human serum using solid-phase extraction and liquid chromatography/positive ion electrospray tandem mass spectrometry. J Mass Spectrom (2000) 0.80
Probing pair-correlated fermionic atoms through correlations in atom shot noise. Phys Rev Lett (2005) 0.80
Meperidine metabolites: identification of N-hydroxynormeperidine and a hydroxy-methoxy derivative of meperidine in biological fluids. Res Commun Chem Pathol Pharmacol (1976) 0.80
Analysis of clonazepam in a tablet dosage form using smallbore HPLC. J Pharm Biomed Anal (1998) 0.80
Aggressive behavior in Huntington's disease: treatment with propranolol. J Clin Psychiatry (1987) 0.80
Reversible dysphagia associated with neuroleptic treatment. J Am Geriatr Soc (2001) 0.80
High-performance liquid chromatography with electrochemical detection of chlorzoxazone and its hydroxy metabolite in serum using solid-phase extraction. J Chromatogr (1986) 0.80
Solution conformation of model polypeptides with the use of particle beam LC/FT-IR spectrometry and electrospray mass spectrometry. J Pharm Biomed Anal (1999) 0.79
Determination of degradation products from the calcium-channel blocker isradipine. J Pharm Biomed Anal (1998) 0.79
Determination of methyldopa in pharmaceutical dosage forms and biological fluids based on oxidation at the tubular carbon electrode. J Pharm Sci (1974) 0.79
Pseudomembranous colitis. Scott Med J (1980) 0.79
Fluorescent analysis of primary aliphatic amines by reaction with 9-isothiocyanatoacridine. J Pharm Sci (1971) 0.79
Evolution of the normal state of a strongly interacting Fermi gas from a pseudogap phase to a molecular Bose gas. Phys Rev Lett (2011) 0.79
Treatment of Huntington's disease with clonazepam. South Med J (1988) 0.78
Liquid chromatographic determination of canrenone in human serum using solid-phase extraction. J Pharm Biomed Anal (1994) 0.78
Manganese requirement and toxicity in patients on home parenteral nutrition. Clin Nutr (1998) 0.78
Separation of non-steroidal anti-inflammatory agents using supercritical fluid chromatography. J Chromatogr (1992) 0.78
The nutritional status of patients receiving home enteral feeding. Clin Nutr (1994) 0.78
Comparative intraoperative concentrations of two cephalosporins with activity against anaerobic bacteria. J Antimicrob Chemother (1989) 0.78
Assay for the simultaneous determination of acetaminophen-caffeine-butalbital in human serum using a monolithic column. J Pharm Biomed Anal (2004) 0.78
Determination of degradation products of sumatriptan succinate using LC-MS and LC-MS-MS. J Pharm Biomed Anal (2001) 0.78
Determination of clonidine in human plasma by cold on-column injection capillary gas chromatography-selected-ion monitoring-mass spectrometry. J Chromatogr (1988) 0.78
Ibuprofen-induced lithium toxicity. South Med J (1989) 0.78
Assessment of distal tip position of long-term central venous feeding catheters using transesophageal echocardiology. JPEN J Parenter Enteral Nutr (2001) 0.78
Taurolin for the prevention of parenteral nutrition related infection: antimicrobial activity and long-term use. Clin Nutr (1993) 0.77
Salmonella infection with colitis. J Infect (1980) 0.77
Solution conformation of model peptides with the use of particle beam LC/FT-IR spectrometry and electrospray mass spectrometry. J Pharm Biomed Anal (1998) 0.77
The use, efficacy and monitoring of artificial nutritional support in a teaching hospital. Scott Med J (1995) 0.77
Determination of gatifloxacin in human plasma by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom (2001) 0.77
Paroxetine treatment of sexual disinhibition in dementia. Am J Psychiatry (1997) 0.77
Validation of bedside measurements of absolute human renal blood flow by a continuous thermodilution technique. Crit Care Med (1992) 0.77
Treatment of coprophagia with carbamazepine. Am J Psychiatry (1995) 0.77
Ticlopidine induced agranulocytosis managed with granulocyte colony stimulating factor. N Z Med J (1998) 0.76
A liquid chromatographic method for the determination of promethazine enantiomers in human urine and serum using solid-phase extraction and fluorescence detection. J Pharm Biomed Anal (1995) 0.76
Quantitative GLC determination of pentylenetetrazol in biological fluids. J Pharm Sci (1975) 0.76
Quantitation of trimipramine enantiomers in human serum by enantioselective high-performance liquid chromatography and mixed-mode disc solid-phase extraction. J Chromatogr B Biomed Sci Appl (1997) 0.76
Lipid deposition in central venous catheters: a solution. Lancet (1988) 0.76
Ethanol flush for the prevention of catheter occlusion. Clin Nutr (1992) 0.76
A case of mania associated with high-dose baclofen therapy. J Clin Psychopharmacol (1992) 0.76
Posttraumatic stress disorder and partial complex seizures. Am J Psychiatry (1986) 0.75